What is the treatment for status epilepticus (seizure lasting more than 5 minutes or 2 or more seizures between which the patient doesn't return to baseline)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Status Epilepticus

Immediately administer intravenous lorazepam 4 mg at 2 mg/min (or 0.1 mg/kg) as first-line treatment, followed by a second-line anticonvulsant agent if seizures persist after 5-10 minutes. 1, 2, 3

Immediate First-Line Treatment: Benzodiazepines

  • Lorazepam 4 mg IV at 2 mg/min is the preferred initial agent, with 64.9% efficacy in terminating overt generalized convulsive status epilepticus 3, 2
  • If seizures continue after 10-15 minutes, administer a second dose of lorazepam 4 mg IV 2
  • Alternative routes when IV access unavailable: IM midazolam 0.2 mg/kg (maximum 6 mg) or intranasal midazolam 1, 4
  • Have airway equipment immediately available before administering any benzodiazepine, as respiratory depression can occur 1, 2

Critical concurrent action: Check fingerstick glucose immediately and correct hypoglycemia while administering benzodiazepines 1

Second-Line Treatment (If Seizures Persist After Benzodiazepines)

Administer ONE of the following second-line agents immediately - do not delay for neuroimaging 1:

Preferred Second-Line Options:

  • Valproate 20-30 mg/kg IV over 5-20 minutes: 88% efficacy with 0% hypotension risk - superior safety profile compared to phenytoin 1
  • Levetiracetam 30 mg/kg IV over 5 minutes: 68-73% efficacy with minimal cardiovascular effects, no cardiac monitoring required 1
  • Fosphenytoin 20 mg PE/kg IV at maximum rate of 150 PE/min: 84% efficacy but 12% hypotension risk requiring continuous ECG and blood pressure monitoring 1
  • Phenobarbital 20 mg/kg IV over 10 minutes: 58.2% efficacy but higher risk of respiratory depression 1

Valproate appears to be the optimal second-line choice due to superior safety profile (no hypotension) while maintaining equivalent efficacy to fosphenytoin 1

Refractory Status Epilepticus (Seizures Continuing Despite Benzodiazepines + One Second-Line Agent)

Initiate continuous EEG monitoring at this stage and proceed to anesthetic agents 1:

Third-Line Anesthetic Agents:

  • Midazolam infusion (first choice for refractory SE):

    • Loading dose: 0.15-0.20 mg/kg IV 1, 4
    • Continuous infusion: Start at 1 mg/kg/min, titrate up by 1 mg/kg/min every 15 minutes to maximum 5 mg/kg/min 1, 4
    • 80% overall success rate with 30% hypotension risk 1
  • Propofol (requires mechanical ventilation):

    • 2 mg/kg bolus, then 3-7 mg/kg/hour infusion 1
    • 73% efficacy with 42% hypotension risk 1
    • Shorter ventilation time (4 days vs 14 days with pentobarbital) 1
  • Pentobarbital (most effective but highest risk):

    • 13 mg/kg bolus, then 2-3 mg/kg/hour infusion 1
    • 92% efficacy but 77% hypotension requiring vasopressors 1

Essential Concurrent Management Throughout Treatment

Simultaneously search for and treat reversible causes 1:

  • Hypoglycemia (check fingerstick glucose immediately)
  • Hyponatremia and other electrolyte abnormalities
  • Hypoxia (maintain airway, provide oxygen)
  • Drug toxicity or withdrawal syndromes
  • CNS infection (meningitis, encephalitis)
  • Ischemic stroke or intracerebral hemorrhage
  • Metabolic derangements

Critical Monitoring Requirements

  • Continuous vital sign monitoring, particularly respiratory status and blood pressure 1, 4
  • Prepare for mechanical ventilation before initiating any anesthetic agent 1
  • Continuous EEG monitoring for refractory cases to guide titration and detect non-convulsive seizure activity 1

Common Pitfalls to Avoid

  • Never use neuromuscular blockers alone (e.g., rocuronium) - they only mask motor manifestations while allowing continued electrical seizure activity and brain injury 1
  • Do not skip to third-line agents until benzodiazepines and at least one second-line agent have been tried 1
  • Do not delay anticonvulsant administration for neuroimaging - CT scanning can be performed after seizure control is achieved 1
  • Nothing should be put in the mouth and no oral medications should be given during active seizures 5
  • Do not restrain the patient - instead, help them to the ground, place in recovery position, and clear the area 5

Activation of Emergency Medical Services

Activate EMS immediately for 5:

  • First-time seizure
  • Seizures lasting >5 minutes
  • Multiple seizures without return to baseline between episodes
  • Seizures in water, with traumatic injuries, difficulty breathing, or choking
  • Seizure in infant <6 months or pregnant individuals
  • Patient not returning to baseline within 5-10 minutes after seizure stops

References

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Midazolam Infusion for Status Epilepticus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.